Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus aureus cell surface structures represent a diverse collection of macromolecules that constitute the bacterial cell envelope, serving as the primary interface between the pathogen and its host. These structures include a thick, cross-linked peptidoglycan layer, wall teichoic acids (WTA), lipoteichoic acids (LTA), and a variety of cell wall-anchored (CWA) proteins, such as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) (1.2.1, 1.3.1). Biologically, these components are essential for maintaining cell shape, resisting osmotic pressure, and facilitating critical processes like adhesion to host tissues, biofilm formation, and evasion of the host immune response (1.1.2, 1.2.2). Because of their essentiality and accessibility, these structures are the primary targets for many clinical antibiotics, including beta-lactams and glycopeptides, which inhibit cell wall synthesis (1.1.3, 1.3.5). Furthermore, novel therapeutic strategies are increasingly focusing on specific surface proteins and teichoic acid biosynthetic pathways to address the challenge of multidrug-resistant strains, such as methicillin-resistant S. aureus (MRSA) (1.4.2, 1.4.3).
Inhibition of cell wall synthesis (transpeptidation and transglycosylation), disruption of membrane integrity, inhibition of teichoic acid biosynthesis, and neutralization of surface adhesins (1.1.2, 1.4.1, 1.4.2).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus cell surface structures.